医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
BCAX · Bicara Therapeutics Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Bicara Therapeutics Inc.（BCAX）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $3.5M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-10。
买入 Bought—
卖出 Sold$3.5M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-08 | Cohlhepp Ryan Director, President, COO & Interim CEO | 卖出 Sell | 17,500 | $22.90 | $401K | SEC |
| 2026-08-10 | Cohlhepp Ryan Director, President and COO | 卖出 Sell | 18,750 | $27.98 | $525K | SEC |
| 2026-08-10 | Mazumdar Claire Chief Executive Officer, Director | 卖出 Sell | 10,000 | $27.98 | $280K | SEC |
| 2026-08-10 | Hyep Ivan Chief Financial Officer | 卖出 Sell | 12,500 | $27.97 | $350K | SEC |
| 2026-07-10 | Mazumdar Claire Chief Executive Officer, Director | 卖出 Sell | 10,000 | $28.42 | $284K | SEC |
| 2026-07-08 | Hyep Ivan Chief Financial Officer | 卖出 Sell | 28,000 | $28.85 | $808K | SEC |
| 2026-07-08 | Cohlhepp Ryan Director, President and COO | 卖出 Sell | 28,750 | $28.98 | $833K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-21 | Raben David Officer | 24,777 | $449K | |
| 2026-09-08 | Cohlhepp Ryan Officer, Director | 17,500 | $396K | 10b5-1 |
| 2026-09-08 | Hyep Ivan Officer | 12,500 | $283K | 10b5-1 |
| 2026-08-10 | Cohlhepp Ryan Officer, Director | 18,750 | $522K | 10b5-1 |
| 2026-08-10 | Hyep Ivan Officer | 12,500 | $348K | 10b5-1 |
| 2026-08-10 | Mazumdar Claire Officer, Director | 10,000 | $278K | 10b5-1 |
| 2026-07-10 | Mazumdar Claire Officer, Director | 10,000 | $297K | 10b5-1 |
| 2026-07-08 | Raben David Officer | 50,000 | $1.4M | |
| 2026-07-08 | Cohlhepp Ryan Officer, Director | 28,750 | $870K | 10b5-1 |
| 2026-07-08 | Hyep Ivan Officer | 28,000 | $847K | 10b5-1 |
内部人 Insiders
Cohlhepp Ryan、Mazumdar Claire、Hyep Ivan